Kelley R. Branch, MD, MSc, FACC, FSCCT is an Associate Professor in Cardiology at the University of Washington in Seattle, WA. Dr. Branch has been part of the University of Washington faculty since 2004 and his research focus is in clinical trials and advanced cardiac imaging. He also obtained a Master’s degree in Epidemiology and Clinical Trials at the University of Washington. His research support included the National Institute of Health KL2 Mentored Training Grant and is currently supported by grants from the NIH and clinical trials. He is Associate Director of the Clinical Trials Service Unit, which facilitates large international clinical trials, and is Direction of Cardiovascular Clinical Trials Unit at the University of Washington. He is also on the Board of Directors for the Society of Cardiovascular CT and on the Editorial Board of European Radiology. Dr. Branch's other awards include the American College of Cardiology/Merck Fellowship Award, the Cardiology Teaching Excellence Award, the University of Washington School of Medicine Outstanding CME Teacher and the ACC Emerging Faculty award. His most recent research has been dissemination of the completed rivaroxaban/aspirin arm of COMPASS clinical trial that showed significant cardiovascular benefit of the combined therapy. He is a fellow of the American College of Cardiology and the Society of Cardiovascular CT.